Form 8-K - Current report:
SEC Accession No. 0001193125-25-160804
Filing Date
2025-07-18
Accepted
2025-07-18 06:09:37
Documents
16
Period of Report
2025-07-16
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d909980d8k.htm   iXBRL 8-K 51102
2 EX-3.1 d909980dex31.htm EX-3.1 5936
3 EX-3.2 d909980dex32.htm EX-3.2 76658
4 EX-10.1 d909980dex101.htm EX-10.1 34282
5 EX-99.1 d909980dex991.htm EX-99.1 159903
  Complete submission text file 0001193125-25-160804.txt   523527

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bpmc-20250716.xsd EX-101.SCH 2884
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bpmc-20250716_lab.xml EX-101.LAB 17981
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bpmc-20250716_pre.xml EX-101.PRE 11281
19 EXTRACTED XBRL INSTANCE DOCUMENT d909980d8k_htm.xml XML 3743
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 251132571
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)